Mind Medicine (MindMed) Inc. Share Price Other OTC
Equities
MMEDF
CA60255C1095
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 612M 51.08B |
---|---|---|---|---|---|
Net income 2024 * | -94M -7.84B | Net income 2025 * | -106M -8.84B | EV / Sales 2024 * | - |
Net cash position 2024 * | 184M 15.37B | Net cash position 2025 * | 99.5M 8.3B | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.37
x | P/E ratio 2025 * |
-5.81
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.59% |
Latest transcript on Mind Medicine (MindMed) Inc.
Managers | Title | Age | Since |
---|---|---|---|
Robert Barrow
CEO | Chief Executive Officer | - | 14/21/14 |
Schond Greenway
DFI | Director of Finance/CFO | 52 | 23/22/23 |
Miri Wernli
PSD | President | 71 | 28/20/28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andreas Krebs
BRD | Director/Board Member | 66 | 29/21/29 |
Suzanne Bruhn
BRD | Director/Board Member | 60 | 11/22/11 |
David Gryska
BRD | Director/Board Member | 68 | 21/23/21 |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+48.20% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |